Cargando...

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community

BACKGROUND: People with opioid dependence and HIV are concentrated within criminal justice settings (CJS). Upon release, however, drug relapse is common and contributes to poor HIV treatment outcomes, increased HIV transmission risk, reincarceration and mortality. Extended-release naltrexone (XR-NTX...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Contemp Clin Trials
Autores principales: Di Paola, Angela, Lincoln, Thomas, Skiest, Daniel J., Desabrais, Maureen, Altice, Frederick L., Springer, Sandra A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283549/
https://ncbi.nlm.nih.gov/pubmed/25240704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2014.09.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!